Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$29.25
-0.5%
$29.88
$28.25
$37.44
$65.29B0.535.09 million shs12.47 million shs
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
$11.11
$11.16
$9.90
$11.98
$36.77MN/A7,280 shs2 shs
Kane Biotech Inc. stock logo
KNE
Kane Biotech
C$0.13
-3.8%
C$0.11
C$0.05
C$0.17
C$16.48M0.56149,397 shs31,500 shs
Insperity, Inc. stock logo
NSP
Insperity
$104.17
-4.4%
$103.13
$90.80
$128.91
$3.92B1.14330,053 shs415,094 shs
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
$18.44
$18.12
$5.80
$20.96
$1.94B2.081.87 million shs8 shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
-0.31%+2.01%-1.61%-0.91%-21.26%
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
0.00%0.00%0.00%-1.24%+5.61%
Kane Biotech Inc. stock logo
KNE
Kane Biotech
+4.00%0.00%+23.81%+62.50%+18.18%
Insperity, Inc. stock logo
NSP
Insperity
-0.55%+1.99%+3.11%-4.92%-9.06%
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.2546 of 5 stars
0.05.02.50.02.90.01.3
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/AN/AN/AN/AN/A
Kane Biotech Inc. stock logo
KNE
Kane Biotech
N/AN/AN/AN/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
4.7575 of 5 stars
2.04.03.33.53.11.73.1
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.67
Moderate BuyN/AN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/A
Kane Biotech Inc. stock logo
KNE
Kane Biotech
N/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
2.00
Hold$115.0010.40% Upside
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$33.94B1.92$18.63 per share1.57$26.80 per share1.09
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/A($1.84) per shareN/A
Kane Biotech Inc. stock logo
KNE
Kane Biotech
C$2.74M6.01C$0.01 per share8.50C($0.07) per share-1.79
Insperity, Inc. stock logo
NSP
Insperity
$6.49B0.60$5.14 per share20.27$2.51 per share41.50
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
$150K12,907.39N/AN/A$2.56 per share7.20

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
-$17.87BN/A0.005.801.24N/AN/AN/AN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
-$790KN/A0.00N/AN/AN/A-2.30%N/A
Kane Biotech Inc. stock logo
KNE
Kane Biotech
-C$4.32M-C$0.03N/AN/A-157.48%N/A-32.70%5/23/2024 (Estimated)
Insperity, Inc. stock logo
NSP
Insperity
$171.38M$4.4623.3636.943.132.64%153.34%8.42%5/1/2024 (Confirmed)
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
-$59.35M$0.6229.74N/AN/AN/A-23.31%-18.66%N/A

Latest KNE, GSD, TRIL, NSP, and BTI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Insperity, Inc. stock logo
NSP
Insperity
$1.84N/A-$1.84N/AN/AN/A  
3/26/2024Q4 2023
Kane Biotech Inc. stock logo
KNE
Kane Biotech
N/A-C$0.01-C$0.01-C$0.01N/AC$0.04 million
2/8/2024Q4 2023
Insperity, Inc. stock logo
NSP
Insperity
$0.38$0.46+$0.08$0.40$1.57 billion$1.58 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$2.9310.02%+1.97%N/A1 Years
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/AN/A
Kane Biotech Inc. stock logo
KNE
Kane Biotech
N/AN/AN/AN/AN/A
Insperity, Inc. stock logo
NSP
Insperity
$2.282.19%+11.70%51.12%13 Years
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
N/AN/AN/AN/AN/A

Latest KNE, GSD, TRIL, NSP, and BTI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/13/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/12/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.5%6/28/20246/28/20248/7/2024
2/8/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
Quarterly$0.73309.53%3/21/20243/22/20245/7/2024
2/22/2024
Insperity, Inc. stock logo
NSP
Insperity
Quarterly$0.572.34%3/6/20243/7/20243/21/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
0.67
0.91
0.59
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/A
0.01
0.01
Kane Biotech Inc. stock logo
KNE
Kane Biotech
1,164.24
0.37
0.39
Insperity, Inc. stock logo
NSP
Insperity
3.95
1.11
1.11
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
N/A
19.82
19.82

Ownership

Institutional Ownership

CompanyInstitutional Ownership
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
21.44%
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
24.82%
Kane Biotech Inc. stock logo
KNE
Kane Biotech
N/A
Insperity, Inc. stock logo
NSP
Insperity
93.44%
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
87.15%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
46,0002.23 billion2.23 billionOptionable
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/A3.31 million1.23 millionNot Optionable
Kane Biotech Inc. stock logo
KNE
Kane Biotech
N/A131.84 millionN/ANot Optionable
Insperity, Inc. stock logo
NSP
Insperity
4,40037.65 million35.58 millionOptionable
Trillium Therapeutics Inc. stock logo
TRIL
Trillium Therapeutics
33105.00 million95.44 millionOptionable

KNE, GSD, TRIL, NSP, and BTI Headlines

SourceHeadline
Cachet Bicycle shakes off COVIDCachet Bicycle shakes off COVID
baytoday.ca - February 25 at 12:23 PM
Rejuvenate your look with a trip to Fourth Avenue Medical AestheticsRejuvenate your look with a trip to Fourth Avenue Medical Aesthetics
chch.com - January 30 at 5:32 PM
TTI apprehends motorists for illegal removal of clamps, hunt for four others underwayTTI apprehends motorists for illegal removal of clamps, hunt for four others underway
bulawayo24.com - January 30 at 5:32 PM
BridgeBio raises $1.25bn, and other biotech financingsBridgeBio raises $1.25bn, and other biotech financings
pharmaphorum.com - January 19 at 7:18 AM
Ratio Therapeutics Raises $50M in Series B FinancingRatio Therapeutics Raises $50M in Series B Financing
precisionmedicineonline.com - January 17 at 1:39 PM
Leiomyosarcoma Drug Pipeline Report 2023 - ResearchAndMarkets.comLeiomyosarcoma Drug Pipeline Report 2023 - ResearchAndMarkets.com
businesswire.com - November 10 at 1:22 PM
Mirati Therapeutics Stock (NASDAQ:MRTX), Analyst Ratings, Price Targets, PredictionsMirati Therapeutics Stock (NASDAQ:MRTX), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 8 at 1:30 AM
The Global T-Cell therapy Market size is expected to reach $9.2 billion by 2030, rising at a market growth of 17.5% CAGR during the forecast periodThe Global T-Cell therapy Market size is expected to reach $9.2 billion by 2030, rising at a market growth of 17.5% CAGR during the forecast period
uk.finance.yahoo.com - July 31 at 9:03 AM
Ratio Therapeutics unveils new research and development facilityRatio Therapeutics unveils new research and development facility
biopharma-reporter.com - May 15 at 10:33 AM
WHO Red Flags Punjab-Made Cough Syrup In Fresh Alert: Can Cause Even DeathWHO Red Flags Punjab-Made Cough Syrup In Fresh Alert: 'Can Cause Even Death'
msn.com - April 26 at 12:18 AM
Leukemia Therapeutics Global Market Report 2023Leukemia Therapeutics Global Market Report 2023
uk.finance.yahoo.com - April 4 at 10:35 AM
Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with MerckRatio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
finance.yahoo.com - March 28 at 9:12 AM
Trillium House, an affordable housing project in Warrenton, close to completionTrillium House, an affordable housing project in Warrenton, close to completion
dailyastorian.com - January 10 at 12:26 AM
FDA Grants Fast Track Designation to Tvardi Therapeutics’ TTI-101 for Hepatocellular CarcinomaFDA Grants Fast Track Designation to Tvardi Therapeutics’ TTI-101 for Hepatocellular Carcinoma
nz.finance.yahoo.com - October 19 at 9:39 AM
Cardiff Oncology: 41% Loss In One Day For A Best-In-Class Colorectal Cancer TreatmentCardiff Oncology: 41% Loss In One Day For A Best-In-Class Colorectal Cancer Treatment
seekingalpha.com - September 14 at 9:48 AM
Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of DirectorsZentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors
nz.finance.yahoo.com - September 12 at 7:55 AM
Pfizer: Deal For Global Blood Therapeutics Carries Risk - More M&A Is NeededPfizer: Deal For Global Blood Therapeutics Carries Risk - More M&A Is Needed
seekingalpha.com - August 17 at 11:07 AM
TTI reviews parking modelTTI reviews parking model
chronicle.co.zw - August 10 at 10:41 PM
TTI working round the clock to configure its systemsTTI working round the clock to configure its systems
chronicle.co.zw - August 10 at 10:41 PM
Pfizer in advanced talks to buy firm making sickle cell drugsPfizer in advanced talks to buy firm making sickle cell drugs
pmnewsnigeria.com - August 7 at 3:57 AM
10 Psychedelics CEOs To Pay Attention To In 202210 Psychedelics CEOs To Pay Attention To In 2022
markets.businessinsider.com - June 22 at 10:08 AM
Highlights from ASCO Annual Meeting 2022Highlights from ASCO Annual Meeting 2022
healio.com - June 15 at 1:37 PM
Chlormethine gel may be more effective than ointment for mycosis fungoidesChlormethine gel may be more effective than ointment for mycosis fungoides
healio.com - May 27 at 4:34 PM
Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling?Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling?
edition.cnn.com - May 20 at 2:06 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

British American Tobacco logo

British American Tobacco

NYSE:BTI
British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands. It also distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Global System Dynamics logo

Global System Dynamics

NASDAQ:GSD
Global System Dynamics, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses its search on the farming and national security sectors, including farming related operations and businesses that support the farming industry. The company was formerly known as Gladstone Acquisition Corporation. Global System Dynamics, Inc. was incorporated in 2021 and is based in Houston, Texas.
Kane Biotech logo

Kane Biotech

CVE:KNE
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Insperity logo

Insperity

NYSE:NSP
Insperity, Inc. engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States. It offers its HR services through its workforce optimization and workforce synchronization solutions that include a range of human resources functions, such as payroll and employment administration, employee benefits, workers' compensation, government compliance, performance management, and training and development services. The company also provides Insperity Premier, a cloud-based human capital management platform that offers professional employer organization HR outsourcing solutions to its clients; people management services; and employer liability management services, as well as solutions for middle market. In addition, it offers MarketPlace, an e-commerce portal that offers a range of products and services; and Workforce Acceleration, a human capital management and payroll services solution; integrated payroll; benefits administration; HR administration and employee onboarding; time and attendance; performance management; reporting and analytics; recruiting; employment screening; retirement; and insurance services. The company was formerly known as Administaff, Inc. and changed its name to Insperity, Inc. in March 2011. Insperity, Inc. was founded in 1986 and is headquartered in Kingwood, Texas.
Trillium Therapeutics logo

Trillium Therapeutics

NASDAQ:TRIL
Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.